T-ALL
Clinical trials for T-ALL explained in plain language.
Never miss a new study
Get alerted when new T-ALL trials appear
Sign up with your email to follow new studies for T-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for T-ALL patients: targeted drug shows promise in early trial
Disease control Recruiting nowThis study tests a drug called isatuximab in adults with T-cell acute lymphoblastic leukemia (T-ALL) that has come back or not responded to standard treatment. About 40 participants will receive isatuximab alongside chemotherapy to see if it helps eliminate leukemia cells from th…
Matched conditions: T-ALL
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Engineered immune cells take aim at childhood leukemias in early trial
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD123-CAR T-cell therapy for children and young adults (up to age 21) with certain blood cancers that have come back or not responded to standard treatment. The therapy uses the patient's own or a donor's immune cells, which are…
Matched conditions: T-ALL
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC